Coagulation Testing and Techniques

Coagulation tests are essential tools used to evaluate the blood's ability to form clots and stop
bleeding. They are crucial for diagnosing and monitoring bleeding disorders, thrombosis, and
conditions affecting the coagulation cascade. Here are some key points on coagulation tests:
1. Common Coagulation Tests
 Prothrombin Time (PT)
o Measures the time it takes for blood to clot via the extrinsic and common
pathways.
o Evaluates factors I (fibrinogen), II (prothrombin), V, VII, and X.
o Often used to monitor patients on warfarin therapy.
o Reported as PT in seconds and INR (International Normalized Ratio).
 Activated Partial Thromboplastin Time (aPTT)
o Assesses the intrinsic and common pathways of the coagulation cascade.
o Evaluates factors I, II, V, VIII, IX, X, XI, and XII.
o Commonly used to monitor heparin therapy.
o Reported as aPTT in seconds.
 Thrombin Time (TT)
o Measures the conversion of fibrinogen to fibrin by thrombin.
o Prolonged in conditions with low fibrinogen levels, dysfibrinogenemia, or the
presence of thrombin inhibitors (e.g., heparin).
 Fibrinogen Level
o Quantifies the amount of fibrinogen in the blood.
o Decreased in disseminated intravascular coagulation (DIC), liver disease, or
congenital fibrinogen deficiencies.
o Increased in inflammatory states, pregnancy, and certain malignancies.
 D-Dimer
o Measures the presence of fibrin degradation products.
o Elevated in conditions with active clot formation and breakdown, such as DIC,
venous thromboembolism (VTE), or deep vein thrombosis (DVT).
o Used as a screening test to rule out thromboembolic disorders.
2. Specialized Coagulation Tests
 Factor Assays
o Specific tests to measure the activity of individual clotting factors (e.g., Factor
VIII, IX).
o Used to diagnose specific factor deficiencies like hemophilia.
 Mixing Studies
o Helps differentiate between factor deficiencies and inhibitors.
o Patient plasma is mixed with normal plasma to see if a prolonged PT or aPTT
corrects.
o If corrected, suggests a factor deficiency; if not, suggests the presence of an
inhibitor.
 Anti-Xa Assay
o Measures the activity of anticoagulants like low-molecular-weight heparin
(LMWH) and direct oral anticoagulants (DOACs) by assessing their inhibition of
Factor Xa.
o Useful for monitoring anticoagulant therapy, especially in cases of renal
impairment.
 Platelet Function Tests
o Includes tests like the platelet aggregation test and PFA-100.
o Evaluates the function of platelets in clot formation.
o Used to diagnose platelet function disorders like von Willebrand disease.
3. Clinical Applications
 Monitoring Anticoagulant Therapy
o PT/INR for warfarin, aPTT for unfractionated heparin, and Anti-Xa assay for
LMWH or DOACs.
 Diagnosing Bleeding Disorders
o Prolonged PT/aPTT can indicate hemophilia, von Willebrand disease, or liver
disease.
 Assessing Thrombotic Risk
o D-Dimer for screening of thromboembolic events.
 Preoperative Screening
 o PT, aPTT, and platelet counts are often part of pre-surgical evaluations to assess
bleeding risk.
4. Interpreting Coagulation Tests
 Normal vs. Abnormal Results
o Normal PT, aPTT, and TT suggest a properly functioning coagulation system.
o Abnormal results require further investigation, considering patient history,
medication use, and potential genetic conditions.
 Interferences
o Factors like liver dysfunction, vitamin K deficiency, anticoagulant use, and
certain medications can affect test results.
o Pre-analytical errors such as improper sample collection can also impact results.
Techniques for collecting coagulation specimens
Coagulation tests are vital in diagnosing and managing patients with bleeding or clotting
disorders, ensuring appropriate treatment and management strategies
Collecting specimens for coagulation testing requires careful attention to technique and proper
handling to ensure accurate results. Here are the key techniques and considerations for collecting
coagulation specimens:
1. Proper Patient Preparation
 Fasting: While fasting is not usually required for coagulation tests, ensure the patient
follows any specific instructions provided by the physician, particularly if multiple tests
are ordered.
 Medication Review: Be aware of medications that can affect coagulation (e.g.,
anticoagulants, aspirin). Document any relevant medications, as they can influence test
results.
 Relaxation: Ensure the patient is relaxed and calm, as stress can potentially affect
coagulation results.
2. Site Selection and Preparation
 Vein Selection: The median cubital vein in the antecubital fossa is commonly used for
blood collection. Avoid using veins that are scarred, thrombosed, or near IV lines.
 Skin Antisepsis: Clean the puncture site with 70% isopropyl alcohol, allowing it to air
dry completely. Do not touch the site after cleaning.
3. Collection Technique
  Order of Draw: For coagulation testing, the light blue-top tube containing sodium citrate
(3.2% or 3.8%) should be collected first or immediately after a non-additive tube to avoid
contamination from other additives.
 Blood-to-Anticoagulant Ratio:
o The standard ratio is 9 parts blood to 1 part anticoagulant. Under-filling or over-
filling the tube can lead to inaccurate test results.
o For patients with high hematocrit levels (greater than 55%), the volume of
anticoagulant may need adjustment to maintain the correct blood-to-anticoagulant
ratio.
 Tube Mixing: Immediately after collection, gently invert the tube 3-4 times to mix the
blood with the anticoagulant. Avoid vigorous shaking to prevent hemolysis or activation
of platelets.
4. Minimizing Hemolysis
 Needle Size: Use an appropriately sized needle (typically 21-23 gauge) to prevent
hemolysis.
 Avoiding Excessive Pressure: Do not apply excessive pressure to the syringe plunger
when transferring blood to the collection tube, as this can cause hemolysis.
 Tourniquet Time: Apply the tourniquet for no longer than 1 minute to prevent
hemoconcentration and possible changes in coagulation factors.
5. Handling and Transport
 Prompt Processing: After collection, samples should be processed promptly, typically
within 1-2 hours, to avoid deterioration of labile coagulation factors.
 Centrifugation: If plasma is needed, centrifuge the tube at 1500-2000 x g for 10-15
minutes. Separate the plasma from cells as soon as possible.
 Avoid Temperature Extremes: Transport and store specimens at room temperature (18-
24°C). Do not freeze whole blood samples intended for coagulation testing, as this can
cause cell lysis and affect results.
6. Special Considerations
 Line Draws: If drawing from an indwelling catheter or line, discard the first 5 mL of
blood to avoid contamination with heparin or other infusions.
 Pediatric Samples: Use smaller tubes (pediatric light blue-top tubes) for infants or small
children to ensure the correct blood-to-anticoagulant ratio.
 Repeated Testing: If multiple tests are needed or if initial results are abnormal, ensure
that fresh samples are drawn and handled correctly each time.
7. Documentation
 Labeling: Clearly label the specimen with the patient's name, date, time of collection,
and the collector's initials.
 Documentation: Record any factors that might affect test results, such as patient
medication, any issues during collection, or sample handling anomalies.
HANDLING AND PROCESSING COAGULATION SAMPLES
Handling and processing coagulated specimens require careful attention to prevent degradation
of the sample and to ensure that accurate results are obtained. Here’s a guide on how to handle
and process these specimens:
1. Identification and Labeling
 Ensure that all specimens are properly labeled with the patient's name, date of birth,
collection date, time, and any other relevant information.
 Double-check the label for accuracy before processing.
2. Initial Inspection
 Clot Detection: Visually inspect the sample upon receipt. If the sample appears to have
clotted (which is undesirable for coagulation tests), it may need to be rejected, depending
on the test's requirements.
 Volume Check: Verify that the sample volume is adequate for the tests ordered. For
coagulation tests, the blood-to-anticoagulant ratio is crucial (usually 9:1).
3. Centrifugation
 Centrifuge Settings:
o Centrifuge the sample at 1500-2000 x g for 10-15 minutes to separate the plasma
from the cellular components.
o Ensure that the centrifuge is balanced with an equal number of tubes on opposite
sides.
 Post-Centrifugation:
o Immediately separate the plasma from the red blood cells. If there’s a delay, this
can lead to degradation of coagulation factors.
o Use a pipette to carefully transfer the plasma into a clean, labeled tube.
4. Plasma Handling
 Avoiding Contamination: Use sterile, clean pipettes or tips to avoid contamination of
the plasma sample.
  Aliquoting: If multiple tests are required, divide the plasma into separate aliquots. This
reduces the risk of repeated freeze-thaw cycles if the plasma is stored.
5. Storage Conditions
 Short-term Storage:
o If the plasma is not analyzed immediately, store it at room temperature (18-24°C)
or refrigerated (2-8°C) for up to 4 hours.
 Long-term Storage:
o For extended storage, freeze the plasma at -20°C or lower. For coagulation factor
assays, storing at -70°C is often preferred.
o Avoid multiple freeze-thaw cycles as they can degrade labile factors such as
Factor VIII.
6. Thawed Plasma Processing
 Thawing Process:
o Thaw frozen plasma rapidly at 37°C in a water bath to ensure uniform
temperature.
o Mix gently to re-homogenize the plasma. Do not leave the plasma at 37°C for
extended periods as this can lead to deterioration of some factors.
 Recentrifugation:
o After thawing, it may be necessary to recentrifuge the plasma to remove any
precipitates that formed during freezing.
7. Transporting Specimens
 Room Temperature Transport: For most coagulation tests, transport the specimens at
room temperature if they will be tested within a few hours.
 Frozen Transport: If samples are frozen, ensure they are transported on dry ice to
maintain the frozen state until they reach the testing facility.
8. Special Considerations for Hemolyzed or Clotted Samples
 Hemolyzed Samples: If the plasma is hemolyzed, this may interfere with certain
coagulation tests. The sample may need to be rejected and recollected.
 Clotted Samples: For coagulation testing, clotted specimens are typically unacceptable.
If clotting occurs, the sample must be discarded, and a new sample should be collected.
Always ensure proper mixing of blood with the anticoagulant immediately after
collection to prevent clotting.
9. Documentation
  Record Keeping: Document all steps of processing, including any deviations from the
standard protocol, storage conditions, and transport details.
 Communication: If there is any issue with the specimen (e.g., hemolysis, clots), notify
the appropriate personnel or clinician immediately for further instructions.

QUALITY CONTROL MEASURES

Quality control (QC) measures are crucial for ensuring the accuracy and reliability of
coagulation testing. Here’s a list of key quality control measures for coagulation testing:
1. Pre-Analytical Quality Control
 Proper Specimen Collection:
o Ensure correct blood-to-anticoagulant ratio (typically 9:1 for sodium citrate
tubes).
o Use proper venipuncture techniques to avoid hemolysis or clot formation.
o Label samples accurately with patient information and time of collection.
 Sample Handling and Storage:
o Process specimens within the appropriate time frame (typically within 1-2 hours
of collection).
o Store plasma at appropriate temperatures if not tested immediately (room
temperature for short-term, frozen for long-term storage).
o Avoid multiple freeze-thaw cycles for frozen samples to prevent degradation of
coagulation factors.
2. Analytical Quality Control
 Instrument Calibration:
o Regularly calibrate coagulation analyzers according to manufacturer guidelines.
o Use calibration curves and verify instrument calibration with known standards.
 Control Samples:
o Run quality control samples (both normal and abnormal controls) with every
batch of patient tests.
o Use control samples that cover the full range of expected results (e.g., low,
normal, high).
 o Analyze control results before releasing patient results. If control results are out of
range, investigate and correct the issue before proceeding.
 Reagent Management:
o Use only validated, manufacturer-recommended reagents.
o Store reagents as per manufacturer’s instructions (e.g., temperature, light
protection).
o Monitor reagent expiration dates and do not use expired reagents.
o Prepare and handle reagents properly to avoid contamination or degradation.
 Temperature and Environmental Monitoring:
o Maintain and monitor the temperature of instruments, reagents, and storage areas.
o Ensure consistent environmental conditions (e.g., humidity, temperature) in the
lab to prevent variations in test results.
 Periodic Testing of Proficiency Samples:
o Participate in external quality assessment (EQA) or proficiency testing programs
to compare results with other laboratories.
o Review proficiency test results to identify and correct any discrepancies or trends.
 Instrument Maintenance:
o Perform routine maintenance of coagulation analyzers according to manufacturer
guidelines.
o Keep detailed logs of maintenance activities, repairs, and instrument downtime.
o Regularly inspect and clean instrument components such as cuvettes and pipettes.
3. Post-Analytical Quality Control
 Result Verification:
o Review and verify all test results before reporting. Investigate any unexpected or
abnormal results.
o Compare current results with previous patient results (if available) to identify any
significant changes or trends.
 Documentation and Record Keeping:
o Maintain accurate records of all QC activities, including control results,
calibration data, maintenance logs, and proficiency test outcomes.
 o Ensure traceability of results to specific reagents, calibrators, and controls used
during testing.
 Reporting Protocols:
o Implement standardized protocols for reporting critical values and abnormal
results promptly to the appropriate healthcare provider.
o Use automated systems to minimize transcription errors in reporting results.
4. Ongoing Quality Improvement
 Regular Training and Competency Assessment:
o Provide ongoing training for laboratory staff on coagulation testing procedures,
instrument operation, and quality control measures.
o Perform regular competency assessments to ensure staff are proficient in all
aspects of coagulation testing.
 Internal Audits:
o Conduct regular internal audits to review adherence to protocols, identify areas
for improvement, and ensure compliance with regulatory standards.
o Implement corrective actions based on audit findings to continually improve the
quality of testing.
 Monitoring and Analyzing Trends:
o Monitor QC data over time to identify trends or shifts in performance.
o Analyze trends to detect potential issues early and implement preventive
measures.
 Error Tracking and Root Cause Analysis:
o Track and investigate any errors or discrepancies in testing, whether pre-
analytical, analytical, or post-analytical.
o Conduct root cause analysis for any significant errors and implement corrective
actions to prevent recurrence.